Europe Life Sciences Competitiveness: Addressin...

By João L. Carapinha

March 17, 2026

Europe life sciences competitiveness is under pressure, as detailed in the
EU Medicines Regulation Achievements: EMA’s 2025 Highlights and Future ...
Catalyzing Cardiovascular Health Innovation through Urban Interventions and C...
EMA Approval Submission for Teclistamab Multiple Myeloma Monotherapy
Enhertu Early Breast Cancer: FDA Priority Review for Reducing Recurrence Risk
EMA’s Clinical Trials Guidance for Enhancing Flexibility During Public ...
Portugal Clinical Trials Regulation: A Comprehensive Framework for EU Complia...
Harmonizing Non-Clinical Evaluation of Microbiome Medicinal Products in the EU
CHMP February 2026 Approvals: New Breakthroughs in Medicines and Biosimilars
EMA’s mCombriax Vaccine Recommendation
KEYTRUDA Padcev MIBC Survival: New Era in Treatment Revealed by KEYNOTE-B15 T...
Novartis Drug Discovery Innovation: Advancing Global Health Through Strategic...
BIC LEN HIV Treatment: New Single-Tablet Regimen Shows Promising Results in A...